EP2659881
Lyfjasamsetning með seinkaða losun
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
30.4.2012EP published:
29.11.2017EP application number:
12166110.2
EP translation filed:
1.2.2018Grant published:
15.2.2018EPO information:
European Patent Register
Max expiry date:
29.4.2032Expiry date:
29.4.2026Next due date:
30.4.2026
Title:
A delayed release drug formulation
Timeline
Today
30.4.2012EP application
29.11.2017EP Publication
1.2.2018Translation submitted
15.2.2018Registration published
29.4.2026Expires
Owner
Name:
Tillotts Pharma AGAddress:
Baslerstrasse 5, 4310, Rheinfelden, CH
Inventor
Name:
Bravo Gonzàles, Roberto CarlosAddress:
Binningen, CH
Name:
Buser, ThomasAddress:
Nuglar, CH
Name:
Goutte, Frédéric Jean-ClaudeAddress:
Schwoben, FR
Name:
Basit, Abdul WasehAddress:
MiddlesexHA3 8JB, GB
Name:
Varum, Felipe José OliveiraAddress:
Riehen, CH
Name:
Freire, Ana CristinaAddress:
NN4 8BYNorthampton, GB
Agent
Name:
Novagraaf BrevetsAddress:
Bâtiment O2, 2 rue Sarah Bernhardt CS90017, FR
Classification
Categories:
A61K 9/00, A61K 9/28, A61K 31/606, A61K 47/32, A61K 47/36, A61K 31/196, A61K 31/616, A61K 9/20
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 5.3.2018
Expires: 29.4.2019
Payer: Árnason Faktor
Number: 8
Paid: 8.3.2019
Expires: 29.4.2020
Payer: Árnason Faktor
Number: 9
Paid: 10.3.2020
Expires: 29.4.2021
Payer: Árnason Faktor ehf.
Number: 10
Paid: 10.3.2021
Expires: 29.4.2022
Payer: Árnason Faktor ehf.
Number: 11
Paid: 10.3.2022
Expires: 29.4.2023
Payer: Árnason Faktor ehf.
Number: 12
Paid: 8.3.2023
Expires: 29.4.2024
Payer: Árnason Faktor ehf.
Number: 13
Paid: 7.3.2024
Expires: 29.4.2025
Payer: Árnason Faktor ehf.
Number: 14
Paid: 18.3.2025
Expires: 29.4.2026
Payer: Árnason Faktor ehf.